Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease

Gloria Perez-Rubio, Elizabeth Cordoba-Lanus, Paula Cupertino, Francisco Cartujano-Barrera, Michael A Campos, Ramces Falfan-Valencia

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in developed countries. Although cigarette smoking is the major risk factor, only 10-20% of smokers develop COPD. The extent of cigarette smoking (pack-years and smoking duration) accounts for only 15% of the variation in lung function, indicating that differences in susceptibility to COPD must exist. We provide an overview of the complexity of nicotine addiction and COPD, with special attention to the involvement of genetic factors. The following aspects are discussed in the present article: (1) epidemiology in Mexico and (2) a review of the published literature on genetic association studies using the National Center for Biotechnology Information database of the United States as a search tool. COPD is unique among complex genetic diseases where an environmental risk factor is known and the level of exposure can be documented with some precision. The high morbidity and mortality associated with COPD and its chronic and progressive nature has prompted the use of molecular genetic studies to identify susceptibility factors for the disease. Biomedical research has a remarkable set of tools to aid in the discovery of genes and polymorphisms. We present a review of the most relevant genetic associations in nicotine addiction and COPD.

Original languageEnglish (US)
Pages (from-to)36-54
Number of pages19
JournalRevista de Investigacion Clinica
Volume71
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Genetic Predisposition to Disease
Nicotine
Chronic Obstructive Pulmonary Disease
Smoking
Genetic Association Studies
Morbidity
Information Centers
Inborn Genetic Diseases
Mortality
Disease Susceptibility
Biotechnology
Mexico
Developed Countries
Biomedical Research
Molecular Biology
Epidemiology
Databases
Lung

Keywords

  • Chronic obstructive pulmonary disease
  • Exacerbations
  • Genetic susceptibility
  • HLA
  • Nicotine addiction
  • Single-nucleotide polymorphisms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Perez-Rubio, G., Cordoba-Lanus, E., Cupertino, P., Cartujano-Barrera, F., Campos, M. A., & Falfan-Valencia, R. (2019). Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. Revista de Investigacion Clinica, 71(1), 36-54. https://doi.org/10.24875/RIC.18002617

Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. / Perez-Rubio, Gloria; Cordoba-Lanus, Elizabeth; Cupertino, Paula; Cartujano-Barrera, Francisco; Campos, Michael A; Falfan-Valencia, Ramces.

In: Revista de Investigacion Clinica, Vol. 71, No. 1, 01.01.2019, p. 36-54.

Research output: Contribution to journalReview article

Perez-Rubio, G, Cordoba-Lanus, E, Cupertino, P, Cartujano-Barrera, F, Campos, MA & Falfan-Valencia, R 2019, 'Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease', Revista de Investigacion Clinica, vol. 71, no. 1, pp. 36-54. https://doi.org/10.24875/RIC.18002617
Perez-Rubio, Gloria ; Cordoba-Lanus, Elizabeth ; Cupertino, Paula ; Cartujano-Barrera, Francisco ; Campos, Michael A ; Falfan-Valencia, Ramces. / Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease. In: Revista de Investigacion Clinica. 2019 ; Vol. 71, No. 1. pp. 36-54.
@article{d5085ded4c644c0aa1e9c8af5883e902,
title = "Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease",
abstract = "Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in developed countries. Although cigarette smoking is the major risk factor, only 10-20{\%} of smokers develop COPD. The extent of cigarette smoking (pack-years and smoking duration) accounts for only 15{\%} of the variation in lung function, indicating that differences in susceptibility to COPD must exist. We provide an overview of the complexity of nicotine addiction and COPD, with special attention to the involvement of genetic factors. The following aspects are discussed in the present article: (1) epidemiology in Mexico and (2) a review of the published literature on genetic association studies using the National Center for Biotechnology Information database of the United States as a search tool. COPD is unique among complex genetic diseases where an environmental risk factor is known and the level of exposure can be documented with some precision. The high morbidity and mortality associated with COPD and its chronic and progressive nature has prompted the use of molecular genetic studies to identify susceptibility factors for the disease. Biomedical research has a remarkable set of tools to aid in the discovery of genes and polymorphisms. We present a review of the most relevant genetic associations in nicotine addiction and COPD.",
keywords = "Chronic obstructive pulmonary disease, Exacerbations, Genetic susceptibility, HLA, Nicotine addiction, Single-nucleotide polymorphisms",
author = "Gloria Perez-Rubio and Elizabeth Cordoba-Lanus and Paula Cupertino and Francisco Cartujano-Barrera and Campos, {Michael A} and Ramces Falfan-Valencia",
year = "2019",
month = "1",
day = "1",
doi = "10.24875/RIC.18002617",
language = "English (US)",
volume = "71",
pages = "36--54",
journal = "Revista de Investigacion Clinica",
issn = "0034-8376",
publisher = "Instituto Nacional de la Nutricion Salvador Zubiran",
number = "1",

}

TY - JOUR

T1 - Role of genetic susceptibility in nicotine addiction and chronic obstructive pulmonary disease

AU - Perez-Rubio, Gloria

AU - Cordoba-Lanus, Elizabeth

AU - Cupertino, Paula

AU - Cartujano-Barrera, Francisco

AU - Campos, Michael A

AU - Falfan-Valencia, Ramces

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in developed countries. Although cigarette smoking is the major risk factor, only 10-20% of smokers develop COPD. The extent of cigarette smoking (pack-years and smoking duration) accounts for only 15% of the variation in lung function, indicating that differences in susceptibility to COPD must exist. We provide an overview of the complexity of nicotine addiction and COPD, with special attention to the involvement of genetic factors. The following aspects are discussed in the present article: (1) epidemiology in Mexico and (2) a review of the published literature on genetic association studies using the National Center for Biotechnology Information database of the United States as a search tool. COPD is unique among complex genetic diseases where an environmental risk factor is known and the level of exposure can be documented with some precision. The high morbidity and mortality associated with COPD and its chronic and progressive nature has prompted the use of molecular genetic studies to identify susceptibility factors for the disease. Biomedical research has a remarkable set of tools to aid in the discovery of genes and polymorphisms. We present a review of the most relevant genetic associations in nicotine addiction and COPD.

AB - Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality in developed countries. Although cigarette smoking is the major risk factor, only 10-20% of smokers develop COPD. The extent of cigarette smoking (pack-years and smoking duration) accounts for only 15% of the variation in lung function, indicating that differences in susceptibility to COPD must exist. We provide an overview of the complexity of nicotine addiction and COPD, with special attention to the involvement of genetic factors. The following aspects are discussed in the present article: (1) epidemiology in Mexico and (2) a review of the published literature on genetic association studies using the National Center for Biotechnology Information database of the United States as a search tool. COPD is unique among complex genetic diseases where an environmental risk factor is known and the level of exposure can be documented with some precision. The high morbidity and mortality associated with COPD and its chronic and progressive nature has prompted the use of molecular genetic studies to identify susceptibility factors for the disease. Biomedical research has a remarkable set of tools to aid in the discovery of genes and polymorphisms. We present a review of the most relevant genetic associations in nicotine addiction and COPD.

KW - Chronic obstructive pulmonary disease

KW - Exacerbations

KW - Genetic susceptibility

KW - HLA

KW - Nicotine addiction

KW - Single-nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=85062270881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062270881&partnerID=8YFLogxK

U2 - 10.24875/RIC.18002617

DO - 10.24875/RIC.18002617

M3 - Review article

VL - 71

SP - 36

EP - 54

JO - Revista de Investigacion Clinica

JF - Revista de Investigacion Clinica

SN - 0034-8376

IS - 1

ER -